Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives
Best Practice & Research Clinical Gastroenterology · 2025
DOI: 10.1016/j.bpg.2025.101989 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Nanda Provoost und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Barrett's Esophagus (BE) is a precursor lesion of esophageal adenocarcinoma (EAC). To enable early detection of neoplasia, BE patients undergo regular endoscopic surveillance. However, more than 90 % of EAC patients were not previously diagnosed with the precursor BE, indicating that detection practices are inadequate. Screening for BE could be a strategy to detect BE in the general population, bridging the gap in early diagnosis. Given the limitations of affordable and accessible endoscopy methods for widespread use, efforts should prioritize targeted screening of at-risk individuals using less invasive approaches. For instance, the use of cell collection devices coupled with biomarker assays in patients with GERD could offer a more cost-effective solution to identify undiagnosed cases. In this review, we provide a comprehensive overview of the at-risk population for BE, current screening modalities, and future perspectives to pave the way for effective and practical BE screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands.
- Early Cancer Unit, University of Cambridge, Cambridge, UK.
- Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands. Electronic address: j.honing@erasmusmc.nl.
Zitieren
APA
Provoost, N., Fitzgerald, R. C., & Honing, J. (2025). Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.101989
Vancouver
Provoost N, Fitzgerald RC, Honing J. Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.101989
BibTeX
@article{Provoost2025,
author = {Provoost, Nanda and Fitzgerald, Rebecca C and Honing, Judith},
title = {Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2025},
doi = {10.1016/j.bpg.2025.101989}
}
EUVIMED